Insufficient scRNA-seq data for expression of NLRP2B at single-cell level.
Insufficient scRNA-seq data for expression of NLRP2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 97% | 10.38 | 165 / 170 | 0% | 0.01 | 1 / 459 |
prostate | 97% | 11.97 | 237 / 245 | 0% | 0 | 0 / 502 |
brain | 93% | 14.91 | 2457 / 2642 | 0% | 0.00 | 2 / 705 |
thymus | 92% | 7.71 | 603 / 653 | 0% | 0 | 0 / 605 |
spleen | 91% | 6.68 | 219 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 91% | 7.94 | 1213 / 1335 | 0% | 0 | 0 / 0 |
ovary | 91% | 8.56 | 163 / 180 | 0% | 0 | 0 / 430 |
bladder | 90% | 9.71 | 19 / 21 | 0% | 0 | 0 / 504 |
liver | 90% | 9.22 | 203 / 226 | 0% | 0.00 | 1 / 406 |
muscle | 89% | 6.53 | 715 / 803 | 0% | 0 | 0 / 0 |
breast | 88% | 7.80 | 405 / 459 | 0% | 0.00 | 2 / 1118 |
adipose | 88% | 6.14 | 1054 / 1204 | 0% | 0 | 0 / 0 |
lung | 87% | 6.75 | 500 / 578 | 0% | 0.00 | 1 / 1155 |
intestine | 86% | 6.92 | 832 / 966 | 0% | 0.00 | 1 / 527 |
kidney | 78% | 3.83 | 69 / 89 | 0% | 0.00 | 1 / 901 |
esophagus | 77% | 5.56 | 1111 / 1445 | 1% | 0.01 | 1 / 183 |
stomach | 75% | 4.47 | 270 / 359 | 0% | 0.00 | 1 / 286 |
heart | 74% | 3.68 | 634 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 72% | 4.54 | 185 / 258 | 0% | 0 | 0 / 230 |
pancreas | 69% | 3.09 | 225 / 328 | 0% | 0 | 0 / 178 |
skin | 66% | 3.97 | 1200 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 12% | 0.32 | 114 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1900226 | Biological process | negative regulation of NLRP3 inflammasome complex assembly |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
Gene name | NLRP2B |
Protein name | NLR family pyrin domain-containing protein 2B (Pyrin domain-containing protein 2-like protein POP4) (Pyrin-only protein 4) |
Synonyms | NOD24 POP4 CLRX.1 NLRP2P |
Description | FUNCTION: May function as a negative regulator of NF-kappa-B by preventing RELA/p65 phosphorylation at 'Ser-536', thereby inhibiting its transcriptional activity. Through NF-kappa-B regulation may control cytokine release upon Toll-like receptors activation and therefore play a role in modulation of innate immunity. May also play a role in cell cycle progression and apoptotic process. . |
Accessions | ENST00000434992.1 P0DMW2 |